NextCure Presented Results of the Phase 1B Study of Nc410 in Combination With Pembrolizumab at Esmo 2024
NextCure在Esmo 2024上展示了Nc410與Pembrolizumab聯合治療的第10億研究結果。
NextCure Presented Results of the Phase 1B Study of Nc410 in Combination With Pembrolizumab at Esmo 2024
NextCure在Esmo 2024上展示了Nc410與Pembrolizumab聯合治療的第10億研究結果。
譯文內容由第三人軟體翻譯。